Chronic Kidney Disease

Pharmacists can play an important role in avoiding common medication errors for patients receiving direct oral anticoagulants.

Rivaroxaban and apixaban are the most commonly prescribed direct oral anticoagulants, although they may be most effective in different populations.

Assessing stroke benefit and net clinical benefit of anticoagulation is essential in patients with end-stage renal disease and atrial fibrillation.

Parathyroid hormone (Natpara) is indicated to control hypocalcemia in patients with hypoparathyroidism.

Investigators from Michigan Medicine analyzed data from 16,700 individuals in a new study.

Iptacopan demonstrated statistically significant and clinically important reductions in proteinuria for patients with C3 glomerulopathy.

Investigators have identified a novel signaling pathway and enzyme that may further the understanding of blood clot formation in patients with chronic kidney disease.

The results were presented at the American Society of Nephrology Kidney Week 2021.

Difelikefalin treats moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.

Peter Stenvinkel, MD, PhD, FASN, full professor and senior lecturer at Karolinska University Hospital, Karolinska Institutet, discusses what pharmacists can do to support patients in the intervention or prevention of chronic kidney disease.

The research team analyzed links between pesticide exposure and the risk of kidney dysfunction in 41,847 people using data from the USA National Health and Nutrition Examination Survey.

The most common conditions that cause bladder stones are prostate gland enlargement and damaged nerves.

Ten quiz questions to assess your knowledge on common symptoms and treatments for chronic kidney disease.

Regular dialysis or kidney transplants are common treatment options that were disrupted after the beginning of COVID-19.

The agency has given the greenlight to maralixibat after the ICONIC study combined with 5 years of supportive studies that demonstrated the reduction of pruritis.

Nearly 20% of patients with multiple myeloma have a form of the disease in which they make high quantities of a component of monoclonal proteins, which damages the kidneys.

Diabetic kidney disease develops in nearly 40% of patients with diabetes and serves as the leading cause of chronic kidney disease worldwide, according to the study.

Research shows that individuals who had either a severe or mild case of the virus had an increased risk of kidney damage and disease.

Kidney disease is among the most common causes of both hyperkalemia and hypokalemia.

Chronic kidney disease (CKD)-associated pruritus is a systemic itch condition occurring with a high frequency and intensity in patients with CKD undergoing dialysis.

The lower the glomerular filtration rate, the lower the stage, the worse kidney disease is.

Below a certain GFR, clinically significant reductions in plasma glucose cannot be achieved with sodium-glucose transport protein 2 inhibitors.

How should pharmacists manage a patient with diabetes on metformin with GFR below 30?

The drug is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for patients with anemia due to chronic kidney disease (CKD).